Tinus Group won the "2026 Nutrition OEM Benchmarking Strength Enterprise", and the HNC exhibition ended successfully!

On June 17, the 16th China International Health Products Exhibition (HNC 2026) concluded at the Shanghai National Exhibition and Convention Center. Tinus Group, as a global provider of premium healthcare brand services, made a prominent appearance at Booth 21C30 in Hall 2.1, showcasing its comprehensive one-stop service system from R&D to delivery under the theme "Technological Innovation, Quality First," and was awarded the title of "2026 Leading Enterprise in Nutritional Contract Manufacturing."

During the three-day exhibition period, Tinus Group's booth attracted numerous industry professionals, domestic and international brands, and specialized visitors for interactive exchanges. Focusing on the fields of dietary supplements, functional foods, and health foods, the group systematically demonstrated its five core capabilities that underpin its "Super Factory" positioning, providing a professional interpretation of how to deliver high-quality products more efficiently to global consumers.

Focus on innovative R&D to accelerate product iteration.

Research and development remains a key competitive advantage continuously cultivated by Tinus Group. Leveraging its global R&D network across North America and Asia, the company has established evidence-based science as the fundamental principle for product development, showcasing its AI-driven formulation development system at the exhibition. This system employs intelligent algorithms to integrate vast amounts of scientific literature, clinical research data, and real-world evidence, seamlessly combining trend analysis with evidence-based formulation design. It ensures that every core ingredient and synergistic combination undergoes rigorous scientific validation, significantly reducing the time from concept development to pilot production. In applied research on cutting-edge anti-aging ingredients such as ergothioneine and NMN, the group demonstrated several well-documented technological achievements that drew significant attention at the event.

Global production capacity synergy enables more flexible deliveries.

To meet the dual demands of brand clients for supply chain security and flexibility, Tinus Group comprehensively showcased its GMP-compliant production facilities located in the United States, Canada, Hong Kong, China, and other regions at the exhibition. The facility network covers production lines for a wide range of dosage forms—including soft capsules, hard capsules, tablets, powders, nutritional gummies, oral liquids, and drops—enabling both large-scale exports and rapid regional responses, effectively helping clients balance cost and delivery timelines.

Adhere to stringent quality control measures and earn trust through consistent compliance with standards.

Quality forms the cornerstone of our contract manufacturing services. At the exhibition booth, Tinus Group showcased over ten internationally recognized certifications, including c-GMP, HACCP, ISO 22000, FDA compliance, and SGS certification, while demonstrating a comprehensive quality control system covering raw material selection, process monitoring, and final product release to visiting clients. This management framework, developed in accordance with pharmaceutical standards, ensures that every batch of products meets the stringent regulatory requirements of major global markets.

A one-stop, end-to-end service that simplifies implementation

At this exhibition, Tinus Group repeatedly emphasized that its "one-stop" solution goes beyond mere production capacity supply; it encompasses a comprehensive end-to-end process covering market insights, formula development, raw material procurement, packaging design, large-scale production, quality testing, logistics distribution, and compliance support. Brands need only focus on market strategy and brand building, while Tinus Group seamlessly handles the entire complex journey of products—from concept to finished goods.

Empowering brands to expand globally and extend their service offerings.

With Hong Kong, China as its global operational headquarters, Tinus Group's sales and service network has expanded to over 20 countries and regions. At the exhibition, the team shared multiple practical cases that helped brands successfully enter overseas markets, demonstrating the group's value-added services in areas such as market research, product registration, customs clearance and warehousing, and localized training. What we deliver is not just products, but also continuous companionship and professional support throughout a brand's globalization journey.

Honors serve as a testament to our unwavering commitment to moving forward.

During the exhibition, Tinus Group was awarded the title of "2026 Leading Enterprise in Nutritional Contract Manufacturing" for its comprehensive performance in manufacturing management, quality control standards, and service integrity. This industry recognition affirms the Group's long-term dedication to the nutritional contract manufacturing sector and continuous optimization of its service systems, while also validating its philosophy of "technological innovation with quality as the priority."

While the exhibition may have concluded, our commitment to service remains unwavering. Tinus Group extends its sincere gratitude to leaders at all levels, partners, and industry peers for their attention and support. Moving forward, we will continue to strengthen our five core competencies, delivering more reliable solutions, advancing cutting-edge R&D, and providing comprehensive compliance services to continuously empower global health brands.

Tinus Group

Global provider of premium healthcare brand services

www.tinusgroup.com

Follow the Tinus Group

Obtain the latest insights and industry perspectives on the broader healthcare supply chain.